Back Pain, Musculoskeletal Disease
Conditions
Keywords
Back pain, cervicalgia, dorsalgia, lumbalgia, acupuncture
Brief summary
The purpose of this study is to evaluate prospectively the effectiveness of acupuncture as adjunctive therapy in the treatment of spinal pain is the three backbone areas: cervical, thoracic and lumbar pain, under conditions of usual clinical practice as the medical acupuncturist performed acupuncture, with and without supplementary pharmacological treatment during the first 4 weeks of follow up.
Detailed description
Epidemiological, observational, prospective, with two cohorts, naturalistic and non-interventionist study. The disease to be studied is Back pain (cervical, thoracic or lumbar) caused by musculoskeletal pathologies and previously treated with conventional medical treatment with or without treatment currently.
Interventions
None listed
Sponsors
Group G-6
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients of both sexes, aged 18 and over * Patients diagnosed with back pain: cervical, thoracic or lumbar. * Patients who has received appropriate medical treatment for their disease: analgesics, anti-inflammatories, or other treatments, but painful and symptoms persist * Patients that could receive acupuncture treatment in order to reduce the symptoms and reviewed by a medical acupuncturist * Patients with sufficient cultural and educational level to complete the health questionnaires required in the study * Patients who have given their written informed consent to participate in the study
Exclusion criteria
* Patient with any illness and that medical opinions recommended not to participate in the study * Patient can not respond to questionnaires administered during the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| VAS: Visual Analogic Scale of pain | 10 weekly visits | Pain assesment will be evaluated using a Visual Analogic Scale of pain (VAS). This variable will be evaluated in all 10 visits and it will be showed its evolution (decrease) along the study |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sheehan Disability Questionnaire | First Visit (week 1) and Final Visit (week 10) | Sheehan Disability Questionnaire, this validated questionnaire will be administrated in Visit 1 (Basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations |
| Evaluation of the Scale Hospital Anxiety Depression (HAD) | First Visit (week 1) and Final Visit (week 10) | Scale Hospital Anxiety Depression (HAD), this scale will be evaluated using a validated questionnaire administrated in Visit 1 (basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations |
| Health Questionnaire EuroQol-5D | First Visit (week 1) and Final Visit (week 10) | Health Questionnaire EuroQol-5D, this validated questionnaire will be administrated in Visit 1 (Basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations |
| Assessment of sleep with the integrated scale MOS (Medical Outcomes Study) | First Visit (week 1) and Final Visit (week 10) | Assessment of sleep with the integrated scale MOS (Medical Outcomes Study), this scale will be evaluated using a validated questionnaire administrated in Visit 1 (basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations |
| McGill Pain Questionnaire | 10 weekly visits | A secondary evaluation of pain suffered by the patients will be evaluated using the validated McGill Pain Questionnaire. This questionnaire will be adminstrated in all 10 visits and it will be showed its evolution (decrease) along the study |
Countries
Spain
Outcome results
None listed